Doctors as patients aren’t much better at avoiding overuse, study finds
When it comes to avoiding low-value care, doctors are just like the rest of us... More
Does it matter how much time interns spend with patients?
What is the potential impact of trainees spending so little time on direct patients care? More
Fear of dementia could lead to overtreatment
What are the potential consequences of widespread testing for preclinical Alzheimer's Disease? More
Managing your health care in the face of a serious illness
When you're facing a serious illness, navigating the health care system can be just as difficult as managing your physical health. In the latest edition of NPR's Life Kit series, Shannon Brownlee and other experts provide tips on how patients can maintain control over their health care in stressful situations. More
The psychiatric “prescribing cascade”: A patient story
Although medication overload is particularly prevalent in older adults, younger people are not immune to harm from overprescribing, particularly when it comes to drugs for psychiatric conditions. Here is one person's story of harm from the psychiatric drug prescribing cascade. More
It’s time to wake up from the REMS cycle
Can we trust drug companies to monitor and regulate the safety of their own products? More
Should patients bear more of the cost for ambulance rides?
Should patients be on the hook for ambulance rides for non-emergencies? It's not that simple, write Dr. Surafel Tsega and Dr. Harry Cho in JAMA. More
Four ways that health care institutions can promote equity
How health care institutions can address social determinants of health, beyond just screening and referral. More
Why aren’t decision aids for prostate cancer screening working?
Why decision aids aren't affecting patients' decisions about prostate cancer screening... More
Which hospitals sue patients for unpaid medical bills?
It's not the hospitals you might expect... More
Misrepresenting midwifery: CBS story distorts picture of maternity care
A recent CBS "Whistleblower" segment misses the big picture on midwives and maternity care. More
The benefits and harms of lung cancer screening
The latest commentary in the Lown Institute and American Family Physician's "Right Care" series features Dr. Andy Lazris and Dr. Alan Roth on the pros and cons of lung cancer screening. More
When one unnecessary procedure leads to many…
What happens when one low-value test leads to a "cascade" of expensive and harmful procedures? More
The monopolization of health care goes beyond hospitals
We know that consolidation among hospitals and insurance companies leads to higher prices. But what about consolidation in other areas of health care? More
Deprescribing Champions: Maisha Draves
Why measuring the outcomes of deprescribing is key for culture change, from family physician Maisha Draves at Kaiser Permanente. More
Accelerated drug approval has not come with accelerated evidence
Is the FDA's accelerated approval program resulting in better cancer drugs? Two new studies provide insight... More
Is this $2 million gene therapy drug priced “fairly”?
The approval of a new gene therapy to treat spinal muscular atrophy has created a hot debate in the health policy world about whether or not the drug's $2.1 million price tag is too expensive or a fair price. More
The public health epidemic no one is talking about…
While we rush to fix the opioid crisis, are we ignoring another widespread drug problem? More
How pharmacists can be “deprescribing champions”
A group of pharmacists from Lifespan/Rhode Island Hospital answer our questions about how pharmacists can promote deprescribing. More
Is our health care system prepared for a pediatric mental health crisis?
Is our health care system prepared to treat more behavioral health problems in younger people? So far, the answer is no. More